Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9085588
APP PUB NO 20140343283A1
SERIAL NO

14355142

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the technical field of medicine, and specifically provides methods for preparing Icotinib, Icotinib hydrochloride, and intermediates thereof. These methods avoid the use of phosphorus oxychloride, thereby greatly reducing the emission of pollutants, which is of major benefits to the economy and environment.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BETTA PHARMACEUTICALS CO LTD355 XINGZHONG ROAD YUHANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE HANGZHOU ZHEJIANG 311100 HANGZHOU CITY ZHEJIANG PROVINCE 311100

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hu, Shaojing Beijing, CN 32 264
Li, Zongquan Beijing, CN 6 5
Long, Wei Beijing, CN 91 553
Wang, Fei Beijing, CN 1116 10607

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 21, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00